Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News

Tabula Rasa Healthcare In Talks On Possible Divestitures

-Axios Report

byBenzinga Newsdesk

March 30, 2022

1 minute read

-Axios Report

IO Biotech Announces Data From MM1636 Phase 1/2 Clinical Trial To Be Presented At 2022 AACR Annual Meeting

By Bill Haddad

Today, 12:55 PM

Updated Data as of December 1, 2021 from Phase 1/2 study of IO102-IO103 in Combination with Nivolumab in Metastatic Melanoma Three-year Survival Probability of 73% Subgroup analyses including patients with poor

IOBT

News

Natera Calls Advertising Claim Against Guardant ‘Meritless Suit,’ ‘Misleading’

By Benzinga Newsdesk

Today, 12:55 PM

-- Natera, Inc. (NASDAQ:NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, today announced it has been sued by Guardant Health, in an attempt to stop Natera from exposing Guardant

NTRA